Risk factors for development of skin cancer differ between allogenic and autogenic hematopoietic stem cell transplant recipients

J Am Acad Dermatol. 2023 Aug;89(2):375-376. doi: 10.1016/j.jaad.2023.03.033. Epub 2023 Apr 15.

Authors

Chelsea Shope¹, Laura Andrews², Caroline Brailsford², Lara Wine Lee³

Affiliations

¹ College of Medicine, Medical University of South Carolina, Charleston, South Carolina. Electronic address: shopec@musc.edu.
² College of Medicine, Medical University of South Carolina, Charleston, South Carolina.
³ Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina; Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina.

PMID: 37061915
DOI: 10.1016/j.jaad.2023.03.033

No abstract available

Keywords: immunosuppression therapy; skin neoplasms; transplant recipients; transplantation, autologous; transplantation, homologous.

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Risk Factors
Skin Neoplasms* / epidemiology
Skin Neoplasms* / etiology
Transplant Recipients
Transplantation, Autologous
Transplantation, Homologous / adverse effects